메뉴 건너뛰기




Volumn 3, Issue 3, 2009, Pages 156-160

Functional TRPV4 channels and an absence of capsaicin-evoked currents in freshly-isolated, guinea-pig urothelial cells

Author keywords

GSK1016790A; TRPV1; TRPV4; Urinary bladder; Urothelium

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; AMIDE; BENZOTHIOPHENE DERIVATIVE; CAPSAICIN; CAPSAZEPINE; GSK 1016790A; HYPOTONIC SOLUTION; MESSENGER RNA; N [1 [[4 [2 [[(2,4 DICHLOROPHENYL)SULFONYL]AMINO] 3 HYDROXYPROPANOYL] 1 PIPERAZINYL]CARBONYL] 3 METHYLBUTYL] 1 BENZOTHIOPHENE 2 CARBOXAMIDE; RUTHENIUM RED; UNCLASSIFIED DRUG; UROPLAKIN; UROPLAKIN 1A; VANILLOID RECEPTOR 1; VANILLOID RECEPTOR 4;

EID: 67649362003     PISSN: 19336950     EISSN: 19336969     Source Type: Journal    
DOI: 10.4161/chan.3.3.8555     Document Type: Article
Times cited : (47)

References (13)
  • 1
    • 47949102906 scopus 로고    scopus 로고
    • N-((1S)-1-{[4-((2S)-2-{[(2,4-dichlorophenyl)sulfonyl]amino} -3-hydroxypropanoyl)-1-piperazinyl]carbonyl}-3-methylbutyl)-1-benzothiophene-2- carboxamide (GSK1016790A), a novel and potent transient receptor potential vanilloid 4 channel agonist induces urinary bladder contraction and hyperactivity: Part I
    • Thorneloe KS, Sulpizio AC, Lin Z, Figueroa DJ, Clouse AK, McCafferty GP, et al. N-((1S)-1-{[4-((2S)-2-{[(2,4-dichlorophenyl)sulfonyl]amino}-3- hydroxypropanoyl)-1-piperazinyl]carbonyl}-3-methylbutyl)-1-benzothiophene-2- carboxamide (GSK1016790A), a novel and potent transient receptor potential vanilloid 4 channel agonist induces urinary bladder contraction and hyperactivity: Part I. J Pharmacol Exp Ther 2008; 326:432-442
    • (2008) J Pharmacol Exp Ther , vol.326 , pp. 432-442
    • Thorneloe, K.S.1    Sulpizio, A.C.2    Lin, Z.3    Figueroa, D.J.4    Clouse, A.K.5    McCafferty, G.P.6
  • 3
    • 33745726257 scopus 로고    scopus 로고
    • TRPV1 (vanilloid receptor) in the urinary tract: Expression, function and clinical applications
    • DOI 10.1007/s00210-006-0073-2
    • Avelino A, Cruz F. TRPV1 (vanilloid receptor) in the urinary tract: expression, function and clinical applications. Naunyn Schmiedebergs Arch Pharmacol 2006; 373:287-299 (Pubitemid 43999780)
    • (2006) Naunyn-Schmiedeberg's Archives of Pharmacology , vol.373 , Issue.4 , pp. 287-299
    • Avelino, A.1    Cruz, F.2
  • 4
    • 39449102203 scopus 로고    scopus 로고
    • Peripheral TRPV1 receptors as targets for drug development: New molecules and mechanisms
    • DOI 10.2174/138161208783330754
    • Gunthorpe MJ, Szallasi A. Peripheral TRPV1 receptors as targets for drug development: new molecules and mechanisms. Curr Pharm Des 2008; 14:32-41. (Pubitemid 351266982)
    • (2008) Current Pharmaceutical Design , vol.14 , Issue.1 , pp. 32-41
    • Gunthorpe, M.J.1    Szallasi, A.2
  • 5
    • 34548853751 scopus 로고    scopus 로고
    • Activation of urothelial transient receptor potential vanilloid 4 by 4α-phorbol 12,13-didecanoate contributes to altered bladder reflexes in the rat
    • DOI 10.1124/jpet.107.125435
    • Birder L, Kullmann FA, Lee H, Barrick S, de Groat W, Kanai A, et al. Activation of urothelial transient receptor potential vanilloid 4 by 4alpha-phorbol 12,13-didecanoate contributes to altered bladder reflexes in the rat. J Pharmacol Exp Ther 2007; 323:227-235 (Pubitemid 47443274)
    • (2007) Journal of Pharmacology and Experimental Therapeutics , vol.323 , Issue.1 , pp. 227-235
    • Birder, L.A.1    Kullmann, F.A.2    Lee, H.3    Barrick, S.4    De Groat, W.5    Kanai, A.6    Caterina, M.7
  • 8
    • 47949111999 scopus 로고    scopus 로고
    • Systemic activation of the transient receptor potential vanilloid subtype 4 channel causes endothelial failure and circulatory collapse: Part 2
    • Willette RN, Bao W, Nerurkar S, Yue TL, Doe CP, Stankus G, et al. Systemic activation of the transient receptor potential vanilloid subtype 4 channel causes endothelial failure and circulatory collapse: Part 2. J Pharmacol Exp Ther 2008; 326:443-452
    • (2008) J Pharmacol Exp Ther , vol.326 , pp. 443-452
    • Willette, R.N.1    Bao, W.2    Nerurkar, S.3    Yue, T.L.4    Doe, C.P.5    Stankus, G.6
  • 11
    • 59349110748 scopus 로고    scopus 로고
    • V1.9 is required for inflammation-based urinary bladder dysfunction
    • V1.9 is required for inflammation-based urinary bladder dysfunction. Neurosci Lett 2009; 452:28-32.
    • (2009) Neurosci Lett , vol.452 , pp. 28-32
    • Ritter, A.M.1    Martin, W.J.2    Thorneloe, K.S.3
  • 12
    • 62649121036 scopus 로고    scopus 로고
    • Differential Localizations of the Transient Receptor Potential Channels TRPV4 and TRPV1 in the Mouse Urinary Bladder
    • Yamada T, Ugawa S, Ueda T, Ishida Y, Kajita K, Shimada S. Differential Localizations of the Transient Receptor Potential Channels TRPV4 and TRPV1 in the Mouse Urinary Bladder. J Histochem Cytochem 2009; 57:277-287
    • (2009) J Histochem Cytochem , vol.57 , pp. 277-287
    • Yamada, T.1    Ugawa, S.2    Ueda, T.3    Ishida, Y.4    Kajita, K.5    Shimada, S.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.